UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells

Journal of Virology, 1993-07, Vol.67 (7), p.4062-4069

1993

Volltextzugriff (PDF)

Development of a Herpes Simplex Virus Subunit Glycoprotein Vaccine for Prophylactic and Therapeutic Use

Clinical infectious diseases, 1991-11, Vol.13 (Supplement_11), p.S906-S911

Burke, Rae Lyn

1991

Volltextzugriff (PDF)

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

Journal of Virology, 1992-03, Vol.66 (3), p.1622-1634

1992

Volltextzugriff (PDF)

The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine

The Journal of infectious diseases, 1994-11, Vol.170 (5), p.1110-1119

1994

Volltextzugriff (PDF)

Induction of Herpes Simplex Virus gB-Specific Cytotoxic T Lymphocytes in TAP1-Deficient Mice by Genetic Immunization but Not HSV Infection

Virology (New York, N.Y.), 2001-03, Vol.282 (1), p.56-64

2001

Volltextzugriff (PDF)

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes

The Journal of clinical investigation, 1993-03, Vol.91 (3), p.961-968

1993

Volltextzugriff (PDF)

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

The Journal of infectious diseases, 1990-04, Vol.161 (4), p.653-660

1990

Volltextzugriff (PDF)

Cervical Antibody Responses to a Herpes Simplex Virus Type 2 Glycoprotein Subunit Vaccine

The Journal of infectious diseases, 1998-07, Vol.178 (1), p.1-7

1998

Volltextzugriff (PDF)

Disulfide bonds of herpes simplex virus type 2 glycoprotein gB

Journal of Virology, 1996-11, Vol.70 (11), p.7379-7387

1996

Volltextzugriff (PDF)

Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes

The Journal of infectious diseases, 1987-05, Vol.155 (5), p.914-920

1987

Volltextzugriff (PDF)

Association between human immunodeficiency virus and herpes simplex virus type 2 serpositivity among male factory workers in Zimbabwe

The Journal of infectious diseases, 1998-02, Vol.177 (2), p.481

1998

Volltextzugriff (PDF)

Peripherally administered antibodies against amyloid [beta]-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Nature medicine, 2000-08, Vol.6 (8), p.916

2000

Volltextzugriff (PDF)

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Viral immunology, 2000-01, Vol.13 (3), p.329-341

2000

Volltextzugriff (PDF)

Disposition of antigen-presenting liposome in vivo: Effect on presentation of herpes simplex virus antigen rgD

Vaccine, 1994, Vol.12 (3), p.235-242

1994

Volltextzugriff (PDF)

Mucosal antibodies to human cytomegalovirus clycoprotein B Occur following both natural infection and immunization with human cytomegalovirus vaccines

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.387

1996

Volltextzugriff (PDF)

Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB

Journal of Virology, 1996-08, Vol.70 (8), p.5716-5719

1996

Volltextzugriff (PDF)

Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine

The Journal of infectious diseases, 1993-05, Vol.167 (5), p.1045-1052

1993

Volltextzugriff (PDF)

Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs

Vaccine, 1992, Vol.10 (4), p.209-213

1992

Volltextzugriff (PDF)

Herpes simplex virus glycoprotein treatment of recurrent genital herpes

The Journal of infectious diseases, 1988-01, Vol.157 (1), p.156-163

1988

Volltextzugriff (PDF)

MUCOSAL ANTIBODIES TO CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN B (gB) OCCUR FOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH CMV VACCINES.• 973

Pediatric research, 1996-04, Vol.39, p.165-165

1996

Volltextzugriff (PDF)

Affinity Purification of Bacteriophage T4 Proteins Essential for DNA Replication and Genetic Recombination

Proceedings of the National Academy of Sciences - PNAS, 1983-05, Vol.80 (9), p.2442-2446

1983

Volltextzugriff (PDF)

The isolation, characterization and nucleotide sequence of the phosphoglucoisomerase gene of Saccharomyces cerevisiae

Gene, 1988-12, Vol.73 (1), p.153-161

1988

Volltextzugriff (PDF)

Preinfection Prophylaxis with Herpes Simplex Virus Glycoprotein Immunogens: Factors Influencing Efficacy

Journal of general virology, 1989-12, Vol.70 (12), p.3177-3185

1989

Volltextzugriff (PDF)

Detection and characterization of latent HSV RNA by in Situ and northern blot hybridization in guinea pigs

Virology (New York, N.Y.), 1991-04, Vol.181 (2), p.793-797

1991

Volltextzugriff (PDF)

Guinea pig and human cytomegaloviruses do not share cross-reactive neutralizing epitopes

Journal of medical virology, 1995-09, Vol.47 (1), p.48-51

1995

Volltextzugriff (PDF)

26 – 50 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Biological And Medical Sciences
(30)
Animals
(27)
Virology
(27)
Humans
(26)
Microbiology
(24)
Female
(22)
Fundamental And Applied Biological Sciences. Psychology
(22)
Viral Envelope Proteins - Immunology
(22)
Immunology
(20)
Infectious Diseases
(19)
Infections
(16)
Vaccination
(16)
Viral Vaccines - Immunology
(14)
Adult
(13)
Guinea Pigs
(13)
Recurrence
(13)
Herpesvirus 2, Human - Immunology
(12)
Antibodies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells

Development of a Herpes Simplex Virus Subunit Glycoprotein Vaccine for Prophylactic and Therapeutic Use

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine

Induction of Herpes Simplex Virus gB-Specific Cytotoxic T Lymphocytes in TAP1-Deficient Mice by Genetic Immunization but Not HSV Infection

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

Cervical Antibody Responses to a Herpes Simplex Virus Type 2 Glycoprotein Subunit Vaccine

Disulfide bonds of herpes simplex virus type 2 glycoprotein gB

Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes

Association between human immunodeficiency virus and herpes simplex virus type 2 serpositivity among male factory workers in Zimbabwe

Peripherally administered antibodies against amyloid [beta]-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Disposition of antigen-presenting liposome in vivo: Effect on presentation of herpes simplex virus antigen rgD

Mucosal antibodies to human cytomegalovirus clycoprotein B Occur following both natural infection and immunization with human cytomegalovirus vaccines

Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB

Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine

Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs

Herpes simplex virus glycoprotein treatment of recurrent genital herpes

MUCOSAL ANTIBODIES TO CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN B (gB) OCCUR FOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH CMV VACCINES.• 973

Affinity Purification of Bacteriophage T4 Proteins Essential for DNA Replication and Genetic Recombination

The isolation, characterization and nucleotide sequence of the phosphoglucoisomerase gene of Saccharomyces cerevisiae

Preinfection Prophylaxis with Herpes Simplex Virus Glycoprotein Immunogens: Factors Influencing Efficacy

Detection and characterization of latent HSV RNA by in Situ and northern blot hybridization in guinea pigs

Guinea pig and human cytomegaloviruses do not share cross-reactive neutralizing epitopes

Suchergebnisse filtern